tiprankstipranks
Biolidics Ltd. (SG:8YY)
SGX:8YY
Singapore Market

Biolidics Ltd. (8YY) Financial Statements

0 Followers

Biolidics Ltd. Financial Overview

Biolidics Ltd.'s market cap is currently ―. The company's EPS TTM is S$-0.014; its P/E ratio is -0.69; Biolidics Ltd. is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is S$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Jun 21Dec 20Jun 20Dec 19
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsS$ 3.96MS$ 7.67MS$ 10.67MS$ 8.69MS$ 6.03M
Total AssetsS$ 11.42MS$ 15.07MS$ 18.76MS$ 19.37MS$ 9.62M
Total DebtS$ 4.25MS$ 4.78MS$ 5.28MS$ 3.58MS$ 536.63K
Net DebtS$ 289.48KS$ -2.90MS$ -5.39MS$ -5.11MS$ -5.49M
Total LiabilitiesS$ 9.09MS$ 9.78MS$ 10.48MS$ 8.59MS$ 1.86M
Stockholders EquityS$ 2.33MS$ 5.29MS$ 8.27MS$ 10.78MS$ 7.77M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in SGD

Biolidics Ltd. Earnings and Revenue History

Biolidics Ltd. Debt to Assets

Biolidics Ltd. Cash Flow

Biolidics Ltd. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis